The Adult Hip - Master Case Series and Techniques pp 339-350 | Cite as
Sickle Cell Disease
Chapter
First Online:
Abstract
Please check the hierarchy of the section headings and confirm if correct.
References
- 1.Hammer M, Geier KA, Aksoy S. Perioperative care for patients with sickle cell who are undergoing total hip replacement as treatment for osteonecrosis. Orthop Nurs. 2003;22(6):384–97.CrossRefPubMedGoogle Scholar
- 2.Kamath AF, Mcgraw MH, Israelite CL, Kamath AF, Mcgraw MH, Israelite CL. Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease. World J Orthop. 2015;6(10):776–82.CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Jeong GK, Ruchelsman DE. Total hip arthroplasty in sickle cell hemoglobinopathies. J Am Acad Orthop Surg. 2005;13:208–17.CrossRefPubMedGoogle Scholar
- 4.Ilyas I, Moreau P. Simultaneous bilateral total hip arthroplasty in sickle celldisease. J Arthroplast. 2002;17:441–5.CrossRefGoogle Scholar
- 5.Poignard A, Bouhou M, Homma Y, Hernigou P. Septic arthritis of the hip in adults with sickle cell anemia. Orthop Rev. 2011;3:e1.CrossRefGoogle Scholar
- 6.Moran MC, Huo MH, Garvin KL, Pel-licci PM, Salvati EA. Total hip arthroplasty in sickle cell hemoglobinopathy. Clin Orthop. 1993;294:140–8.Google Scholar
- 7.Gunderson C, D’Ambrosia RD, Shoji H. Total hip replacement in patients with sickle-cell disease. J Bone Joint Surg Am. 1977;59:760–2.CrossRefPubMedGoogle Scholar
- 8.Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM. The perioperative complication rate oforthopedic surgery in sickle cell disease: report of the National sickle cell surgery study group. Am J Hematol. 1999;62:129–38.CrossRefPubMedGoogle Scholar
- 9.Clarke HJ, Jinnah RH, Brooker AF, Michaelson JD. Total replacement of the hip for avascular necrosis in sickle cell disease. J Bone Joint Surg Br. 1989;71:465–70.CrossRefPubMedGoogle Scholar
- 10.Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br. 1992;74:367–71.CrossRefPubMedGoogle Scholar
- 11.Bishop AR, Roberson JR, Eckman JR, Fleming LL. Total hip arthroplasty inpatients who have sickle-cell hemoglo-binopathy. J Bone Joint Surg Am. 1988;70:853–5.CrossRefPubMedGoogle Scholar
- 12.Epps C, Castro O. Complications of total hip replacement in sickle cell disease. Orthop Transactions. 1978;2:236–7.Google Scholar
- 13.Hanker GJ, Amstutz HC. Osteonecrosis of the hip in the sickle cell diseases: treatment and complications. J Bone Joint Surg Am. 1988;70:499–506.CrossRefPubMedGoogle Scholar
- 14.Hickman JM, Lachiewicz PF. Results and complications of total hip arthroplastiesin patients with sickle-cell hemoglobin-opathies: role of cementless components. J Arthroplast. 1997;12:420–5.CrossRefGoogle Scholar
- 15.Al-Mousawi F, Malki A, Al-Aradi A, Al-Bagali M, Al-Sadadi A, Booz MM. Total hip replacement in sickle cell disease. Int Orthop. 2002;26:157–61.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Gulati Y, Sharma M, Bharti B, Bahl V, Bohra I. Short term results of cementless total hip arthroplasty in sicklers. Indian J Orthop. 2015;49(4):447–51.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Issa K, Naziri Q, Maheshwari AV, Rasquinha VJ, Delanois RE, Mont MA. Excellent results and minimal complications of total hip arthroplasty in sickle cell hemoglobinopathy at mid-term follow-up using cementless prosthetic components. J Arthroplast. 2013;28:1693–8.CrossRefGoogle Scholar
- 18.Hernigou P, Zilber S, Filippini P, Mathieu G, Poignard A, Galacteros F. Total THA in adult osteonecrosis related to sickle cell disease. Clin Orthop Relat Res. 2008;466:300–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Perfetti DC, Boylan MR, Naziri Q, Khanuja HS, Urban WP. Does sickle cell disease increase risk of adverse outcomes following total hip and knee Arthroplasty? A Nationwide database study. J Arthroplast. 2015;30:547–51.CrossRefGoogle Scholar
- 20.Hug KT, Gupta AK, Wellman SS, Bolognesi MP, Attarian DE. Creation of a femoral cortical window to facilitate total hip arthroplasty in patients with sickle cell hemoglobinopathies. J Arthroplasty. 2013;28(2):323–5. doi: 10.1016/j.arth.2012.06.021. Epub 2012 Aug 3. PMID: 22,868,077CrossRefPubMedGoogle Scholar
- 21.Patel YD, Szczech BW, Patel S, Issa K, Kapadia BH, Mont MA. Management strategies for total hip arthroplasty in sickle cell patients. J Long Term Eff Med Implants. 2014;24(2–3):219–24.CrossRefPubMedGoogle Scholar
Copyright information
© Springer International Publishing AG, part of Springer Nature 2018